Literature DB >> 21612757

Impact of short term use of interdialytic 60% ethanol lock solution on tunneled silicone catheter dysfunction.

A-E Heng1, M H Abdelkader, M Diaconita, A Nony, A Guerraoui, N Caillot, M Rince, P Deteix, B Souweine.   

Abstract

INTRODUCTION: Ethanol lock (EL) is used to reduce catheter infections, but its impact on dialysis catheter dysfunction has not been studied.
METHODS: We analyzed the rate of dialysis silicone catheter dysfunction after an interdialytic 60% EL in an open prospective controlled non crossover cohort study, with each patient being his or her own control. The study was divided into three consecutive 2-week periods: the pre- and post-intervention periods, in which interdialytic standard locks (SL) were used, and the intervention period, in which one EL was instilled during the first week, and two consecutively in the second week. We analyzed the rate of catheter dysfunction (exchange, use of fibrinolytic, reversing the lines, difficulty in instilling or withdrawing fluid) after EL or SL.
RESULTS: In 30 patients, 90 EL were instilled. The rate of catheter dysfunction increased during the EL period (2 - 13%, p < 0.001), and between the two consecutive dialysis sessions before and after EL (p < 0.05). It decreased between the two consecutive dialysis sessions after EL and the following dialysis session after an SL (p < 0.05). No catheter was removed. The urea reduction ratio did not differ in dialysis after an SL and after an EL (0.77 vs. 0.73, p = 0.17).
CONCLUSION: Short term EL is associated with a transient increase in catheter dysfunction, without resulting in catheter removal or decreasing dialysis efficiency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21612757     DOI: 10.5414/cn106559

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  8 in total

Review 1.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis
Journal:  Cochrane Database Syst Rev       Date:  2022-07-18

2.  Ethanol Lock Efficacy and Associated Complications in Children With Intestinal Failure.

Authors:  Ethan A Mezoff; Lin Fei; Misty Troutt; Kim Klotz; Samuel A Kocoshis; Conrad R Cole
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-02-23       Impact factor: 4.016

3.  Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial.

Authors:  María Jesús Pérez-Granda; José María Barrio; Patricia Muñoz; Javier Hortal; Cristina Rincón; Pablo Martin Rabadán; Maria Sagrario Pernia; Emilio Bouza
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

4.  Renal replacement therapy in adult and pediatric intensive care : Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD).

Authors:  Christophe Vinsonneau; Emma Allain-Launay; Clarisse Blayau; Michael Darmon; Damien Ducheyron; Theophile Gaillot; Patrick M Honore; Etienne Javouhey; Thierry Krummel; Annie Lahoche; Serge Letacon; Matthieu Legrand; Mehran Monchi; Christophe Ridel; René Robert; Frederique Schortgen; Bertrand Souweine; Patrick Vaillant; Lionel Velly; David Osman; Ly Van Vong
Journal:  Ann Intensive Care       Date:  2015-12-30       Impact factor: 6.925

5.  Evaluation of the efficacy of an interdialytic "ethanol 40% v/v - enoxaparin 1000 U/mL" lock solution to prevent tunnelled catheter infections in chronic hemodialysis patients: a multi-centre, randomized, single blind, parallel group study.

Authors:  Julien Aniort; Aurélien Piraud; Mireille Adda; Bruno Perreira; Marc Bouiller; Jacques Fourcade; Abdallah Guerraoui; Emilie Kalbacher; Thierry Krumel; Hélène Leray Moragues; Damien Thibaudin; Carlos Gustavo Vela; Guillaume Vernin; Hugo Weclawiak; Lise Bernard; Anne Elisabeth Heng; Bertrand Souweine
Journal:  BMC Nephrol       Date:  2019-04-30       Impact factor: 2.388

6.  Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update.

Authors:  Niccolò Buetti; Jonas Marschall; Marci Drees; Mohamad G Fakih; Lynn Hadaway; Lisa L Maragakis; Elizabeth Monsees; Shannon Novosad; Naomi P O'Grady; Mark E Rupp; Joshua Wolf; Deborah Yokoe; Leonard A Mermel
Journal:  Infect Control Hosp Epidemiol       Date:  2022-04-19       Impact factor: 6.520

7.  A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients--the HEALTHY-CATH trial.

Authors:  Jennifer K Broom; Rathika Krishnasamy; Carmel M Hawley; E Geoffrey Playford; David W Johnson
Journal:  BMC Nephrol       Date:  2012-11-02       Impact factor: 2.388

Review 8.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis; Amanda Burls
Journal:  Cochrane Database Syst Rev       Date:  2018-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.